Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi
申请人:Levina Elizabeth
公开号:US10265318B2
公开(公告)日:2019-04-23
A medicinal drug is provided with activity against gram positive bacteria, mycobacteria and fungi characterized in that it is a compound of the class of pyrimidine derivatives of salicylic aldehyde and perhydropyrimidine-2,4,6-triones selected from a group consisting of tautomeric forms, salt forms, and a cyclic form of pyrylium salts, and with the general formula:
where X1, X3 are selected from the group containing: H, halogen; NO2;
X2, X4 are selected from the group containing: H, halogen;
Z is selected from the group containing: O, NNH2, NOH, perhydropyrimidine-5-ylidene-2,4.6-trione, perhydropyrimidine-5-ylidene-2,4.6-trione, substituted at the nitrogen atom with alkyl, aryl or aralkyl group;
Y is selected from the group containing: H, Na, Li, K.
Further, methods for treating infections, tonsillitis, pneumonia, or wound infections caused by Gram-positive bacteria, mycobacteria and fungi are provided using a therapeutically effective amount of the compound.
提供了一种对革兰氏阳性菌、分枝杆菌和真菌具有活性的药物,其特征在于它是一种水杨醛和过氢嘧啶-2,4,6-三酮的嘧啶衍生物类化合物,该化合物从同分异构体、盐类和环状嘧啶盐组成的组中选出,通式为
其中 X1、X3 选自以下组别H、卤素
X2、X4 选自包含以下物质的组H、卤素;
Z 选自包含以下物质的组O、NNH2、NOH、全氢嘧啶-5-亚基-2,4.6-三酮、全氢嘧啶-5-亚基-2,4.6-三酮,在氮原子上被烷基、芳基或芳烷基取代;
Y 选自以下组别H、Na、Li、K。
此外,还提供了使用治疗有效量的化合物治疗革兰氏阳性菌、分枝杆菌和真菌引起的感染、扁桃体炎、肺炎或伤口感染的方法。